Related Experiment Videos

The future of allogeneic hematopoietic stem cell transplantation: minimizing pain, maximizing gain

M T Little¹, R Storb

¹Fred Hutchinson Cancer Research Center, Clinical Research Division, Transplantation Biology Program, Seattle, Washington 98109, USA. mlittle@fhcrc.org

The Journal of Clinical Investigation

|June 23, 2000

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients: CD3 cells are required.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2002

Engraftment of DLA-haploidentical marrow with ex vivo expanded, retrovirally transduced cytotoxic T lymphocytes.

Blood·2001

Effects of extending the duration of postgrafting immunosuppression and substituting granulocyte-colony-stimulating factor-mobilized peripheral blood mononuclear cells for marrow in allogeneic engraftment in a nonmyeloablative canine transplantation model.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2001

Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect.

Annals of the New York Academy of Sciences·2001

Hematopoietic responses to stress conditions in young dogs compared with elderly dogs.

Blood·2001

Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model.

Blood·2000

See all related articles